CC BY-NC-ND 4.0 · AJP Rep 2018; 08(04): e280-e288
DOI: 10.1055/s-0038-1675343
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Comparison of Birth Outcomes by Gestational Diabetes Screening Criteria

Esa M. Davis
1   Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Christina M. Scifres
2   Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, Oklahoma
,
Kaleab Abebe
1   Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Tina Costacou
3   Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Diane Comer
1   Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Patrick Catalano
4   Department of Obstetrics and Gynecology, Case Western Reserve University, Cleveland, Ohio
,
Hyagriv Simhan
5   Division Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Matthew Freiberg
6   Department of Medicine, Vanderbilt University, Nashville, Tennessee
,
Nancy Day
7   Department of Epidemiology and Psychiatry, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
› Author Affiliations
Funding The project was supported by the University of Pittsburgh CTSI from the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005 and by funding from the AHRQ K12 CER grant number 1K 12HS019461 01.
Further Information

Publication History

22 February 2018

05 September 2018

Publication Date:
29 October 2018 (online)

Abstract

Objectives This study is to examine the association between different diagnostic criteria for gestational diabetes mellitus (GDM) and adverse birth outcomes.

Study Design A retrospective cohort study of 5,937 women with a singleton pregnancy was conducted, who completed GDM screening between 24 to 32 weeks gestational age. Four nonoverlapping groups of women defined as: 1) Normal: glucose challenge test (GCT) <130 mg/dL, 2) elevated GCT + normal oral glucose tolerance test (OGTT): abnormal 1 hour GCT + normal 3 hour OGTT, 3) GDM/International Association of Diabetes in Pregnancy Study Group (IADPSG): abnormal 3 hour OGTT by the IADPSG criteria, and 4) GDM/Carpenter-Coustan (CC): diagnosis per CC criteria. We used logistic regression to examine the association between GDM group classification and main outcome of macrosomia and secondary birth outcomes.

Results Prevalences were GDM/CC 4.6%, GDM/IADPSG 3.0, and 7.6% overall. GDM/IADPSG group was associated with increased macrosomia (adj OR [odd ratio] 1.87; 95% CI [confidence interval]: 1.08–3.25; p = 0.02), while GDM/CC group was associated with increased preterm birth (adj OR 1.75; 95% CI: 1.05–2.80; p = 0.03).

Conclusion Little difference in birth outcomes was found between the two criteria, GDM/CC and GDM/IADPSG. Randomized controlled trials are needed to clarify the risks and benefits of these screening paradigms before their incorporation into clinical practice.

 
  • References

  • 1 Landon MB, Spong CY, Thom E. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14) 1339-1348
  • 2 Metzger BE, Lowe LP, Dyer AR. , et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
  • 3 Metzger BE, Gabbe SG, Persson B. , et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33 (03) 676-682
  • 4 American Diabetes Association. Standards of medical care in diabetes--2012. Diabetes Care 2012; 35 (Suppl, 1): S11-S63
  • 5 Sacks DA, Hadden DR, Maresh M. , et al; HAPO Study Cooperative Research Group. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012; 35 (03) 526-528
  • 6 Scifres CM, Abebe KZ, Jones KA. , et al. Gestational diabetes diagnostic methods (GD2M) pilot randomized trial. Matern Child Health J 2015; 19 (07) 1472-1480
  • 7 Ethridge Jr JK, Catalano PM, Waters TP. Perinatal outcomes associated with the diagnosis of gestational diabetes made by the international association of the diabetes and pregnancy study groups criteria. Obstet Gynecol 2014; 124 (03) 571-578
  • 8 Vandorsten JP, Dodson WC, Espeland MA. , et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013; 29 (01) 1-31
  • 9 Rasmussen KM, Yaktine AL. , eds. Weight Gain During Pregnancy:. Reexamining the Guidelines. Institute of Medicine (U.S.) and National Research Council Committee to Re-examine IOM Pregnancy Weight Guidelines. Washington DC, WA: The National Academies Press; 2009
  • 10 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87 (02) 163-168
  • 11 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. ; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486
  • 12 Mayo K, Melamed N, Vandenberghe H, Berger H. The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol 2015; 212 (02) 224.e1-224.e9
  • 13 Feldman RK, Tieu RS, Yasumura L. Gestational diabetes screening: the International Association of the Diabetes and Pregnancy Study groups compared with Carpenter-Coustan screening. Obstet Gynecol 2016; 127 (01) 10-17
  • 14 Duran A, Sáenz S, Torrejón MJ. , et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care 2014; 37 (09) 2442-2450
  • 15 Landon MB, Mele L, Spong CY. , et al; Eunice Kennedy Shriver National Institute of Child Health, and Human Development (NICHD) Maternal–Fetal Medicine Units (MFMU) Network. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol 2011; 117 (2, Pt 1): 218-224
  • 16 Nohr EA, Vaeth M, Baker JL, Sørensen TI, Olsen J, Rasmussen KM. Pregnancy outcomes related to gestational weight gain in women defined by their body mass index, parity, height, and smoking status. Am J Clin Nutr 2009; 90 (05) 1288-1294
  • 17 Knowler WC, Barrett-Connor E, Fowler SE. , et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (06) 393-403
  • 18 Mello G, Elena P, Ognibene A. , et al. Lack of concordance between the 75-g and 100-g glucose load tests for the diagnosis of gestational diabetes mellitus. Clin Chem 2006; 52 (09) 1679-1684
  • 19 ACOG Practice Bulletin No. ACOG Practice Bulletin No. 190 Summary: Gestational Diabetes Mellitus. Obstet Gynecol 2018; 131 (02) 406-408